EUVIMEDEUVIMED entdecken
Open Access

Metabolic Improvement Mediates the Causal Relationship Between GLP-1 Receptor Agonists and Myocardial Infarction: A Mendelian Randomization and Mediation Analysis Study

Jingkai Tong, Nana Li, Fang Hu iD, Yingying Yue

Diabetes Care · 2026

DOI: 10.2337/dc25-1822 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes Care, 2026. Verfasst von Jingkai Tong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Tianjin First Central Hospital, Tianjin, China. Hauptthemen laut MEDLINE: Myocardial Infarction, Glucagon-Like Peptide-1 Receptor Agonists, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have cardiovascular benefits, but whether this is via metabolic improvements or direct effect remains controversial. This study aimed to explore the causal link between GLP-1RAs and myocardial infarction (MI) and quantify the contribution of metabolic improvements. RESEARCH DESIGN AND METHODS Mendelian randomization (MR) was applied to assess the causal relationship between GLP-1RAs and MI, and two-step MR analysis was applied to quantify the mediating role of metabolic traits. The direct effect of GLP-1RAs on MI was evaluated by multivariate Mendelian randomization (MVMR). Genetic variants associated with GLP-1 receptor (GLP-1R) expression (proxying GLP-1RAs) were used as instrumental variables. Genome-wide association studies (GWAS) data for metabolic traits glycated hemoglobin (HbA1c), BMI, lipid profile, and blood pressure were sourced from the Million Veteran Program, serving as mediators. GWAS data for type 2 diabetes mellitus (T2DM) were obtained from the DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) consortium, and data for MI were sourced from the UK Biobank/Coronary ARtery DIsease Genome wide Replication and Meta-analysis plus The Coronary Artery Disease (CARDIoGRAMplusC4D), serving as outcomes. All GWAS data were restricted to European ancestry. RESULTS Higher GLP-1R expression was correlated with a lower risk of T2DM (odds ratio 0.94 [95% CI 0.92, 0.97]) and MI (0.97 [0.95, 1.00]). Metabolic improvements mediated this association: HbA1c (36.67% [3.89, 69.44]), BMI (28.86% [2.62, 55.10]), triglycerides (18.52% [1.47, 35.57]), HDL-cholesterol (18.28% [1.45, 35.12]), and systolic blood pressure (11.55% [0.33, 22.76]). No direct effect of GLP-1R expression on MI was observed after adjusting for metabolic traits (β = −0.003, P = 0.12). CONCLUSIONS GLP-1RAs protect against MI primarily through metabolic improvements, with no direct effect independent of these pathways. These findings support prioritizing metabolic improvements to reduce cardiovascular risk with GLP-1RAs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionGlucagon-Like Peptide-1 Receptor AgonistsDiabetes Mellitus, Type 2HumansMendelian Randomization AnalysisGenome-Wide Association StudyGlucagon-Like Peptide-1 ReceptorGlycated HemoglobinMediation AnalysisPolymorphism, Single Nucleotide

Substanzen

Glucagon-Like Peptide-1 Receptor AgonistsGlucagon-Like Peptide-1 ReceptorGlycated Hemoglobin

Autor:innen und Institutionen

  • Department of Endocrinology, Tianjin First Central Hospital, Tianjin, China.
  • Teaching Research Department, Tianjin First Central Hospital, Tianjin, China.
  • Department of Cardiology, Tianjin First Central Hospital, Tianjin, China.
  • Clinical Laboratory, Tianjin First Central Hospital, Tianjin, China.

ORCID-Profile: Fang Hu

Förderung

  • Foundation of China

Zitieren

APA

Tong, J., Li, N., Hu, F., & Yue, Y. (2026). Metabolic Improvement Mediates the Causal Relationship Between GLP-1 Receptor Agonists and Myocardial Infarction: A Mendelian Randomization and Mediation Analysis Study. Diabetes Care. https://doi.org/10.2337/dc25-1822

Vancouver

Tong J, Li N, Hu F, Yue Y. Metabolic Improvement Mediates the Causal Relationship Between GLP-1 Receptor Agonists and Myocardial Infarction: A Mendelian Randomization and Mediation Analysis Study. Diabetes Care. 2026. doi:10.2337/dc25-1822

BibTeX
@article{Tong2026,
  author = {Tong, Jingkai and Li, Nana and Hu, Fang and Yue, Yingying},
  title = {Metabolic Improvement Mediates the Causal Relationship Between GLP-1 Receptor Agonists and Myocardial Infarction: A Mendelian Randomization and Mediation Analysis Study},
  journal = {Diabetes Care},
  year = {2026},
  doi = {10.2337/dc25-1822}
}
Kostenlos starten →